Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | June 25, 2026 | June 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 4,739 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 645 · Balance 4,739 F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2026 Filed Jun 29, 2026 20:27 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 645 | $225.00 | $145,125.00 |
DisclosureSEC source: 0001812194-26-000003 · wk-form4_1782764863.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,739 F1 · kind: Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions. Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 22:35 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 532 | $273.03 | $145,251.96 |
DisclosureSEC source: 0001156375-25-000169 · wk-form4_1750977321.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,094 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 00:45 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 748 | $194.10 | $145,186.80 |
DisclosureSEC source: 0001156375-24-000120 · wk-form4_1719449145.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,562 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:18 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 811 | $178.89 | $145,079.79 |
DisclosureSEC source: 0001156375-23-000110 · wf-form4_168796912520967.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,814 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:33 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 693 | $209.44 | $145,141.92 |
DisclosureSEC source: 0001156375-22-000202 · wf-form4_165651320667073.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:20 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 47 | $221.79 | $10,424.13 |
DisclosureSEC source: 0001156375-22-000025 · wf-form4_164322843091815.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 01:20 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 551 | $218.12 | $120,184.12 |
DisclosureSEC source: 0001156375-21-000084 · edgardoc.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:14 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000066 · edgardoc.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.